Neurologist and Alzheimer’s researcher focused on early detection and intervention for cognitive aging. Currently advancing tau-targeted approaches and biomarkers.
Researchers have found that very high levels of p-tau217 in blood correlate with a 38% five-year risk of cognitive impairment, rising to 78% in ten years among symptom-free older adults. The test could help select volunteers for trials, though experts caution it is not yet ready for routine screening.